A Study of Effectiveness and Safety of Whitfield's Solution, Zinc Oxide Nanoparticles Solution and the Combination of Whitfield's and Zinc Oxide Nanoparticles Solution for the Treatment of Fungal Feet Infection

• Status: Not yet recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aimed to study the efficacy of Whitfield's solution, zinc oxide nanoparticles solution, and the combination of Whitfield's and zinc oxide nanoparticles solution in treating fungal feet infection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Collaborator: Dermatological Society of Thailand
• Treatments: Pharmaceutical Solutions; Zinc; Zinc Oxide

Criteria

Inclusion Criteria:

• The patient was diagnosed with a fungal foot infection based on the clinical presentation and a positive result from a microscopic examination for fungus.

• The patient must not have received any prior antifungal therapy, including topical, oral, or intravenous routes, within 36 weeks prior to recruitment.

Exclusion Criteria:

• Patients with conditions other than fungal foot infections, such as bacterial infections or inflammation of the skin on the foot

• Patients with other fungal diseases that require treatment with systemic antifungals, such as onychomycosis or tinea capitis

• Patients who are currently taking immunosuppressants or are immunocompromised.

• Patients who have difficulty applying the medication by themselves.

• Patients who have been treated for fungal foot infection using methods that are not included in the research protocol.